News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
310,751 Results
Type
Article (16154)
Company Profile (61)
Press Release (294534)
Multimedia
Podcasts (81)
Webinars (18)
Section
Business (108622)
Career Advice (506)
Deals (16419)
Drug Delivery (92)
Drug Development (44042)
Employer Resources (59)
FDA (7527)
Job Trends (6819)
News (166653)
Policy (15618)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (516)
Accelerated approval (33)
ADA (14)
Adcomms (14)
Allergies (114)
Alliances (24198)
ALS (91)
Alzheimer's disease (758)
Antibody-drug conjugate (ADC) (220)
Approvals (7941)
Artificial intelligence (329)
ASCO (156)
Autoimmune disease (127)
Automation (23)
Bankruptcy (160)
Best Places to Work (4931)
BIO (31)
BIOSECURE Act (10)
Biosimilars (171)
Biotechnology (30)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (332)
Cancer (2685)
Cardiovascular disease (255)
Career advice (453)
Career pathing (18)
CAR-T (130)
CDC (10)
Cell therapy (353)
Cervical cancer (26)
Clinical research (40180)
Collaboration (1110)
Commercialization (1)
Company closure (1)
Compensation (503)
Complete response letters (60)
COVID-19 (957)
CRISPR (61)
C-suite (920)
Cystic fibrosis (68)
Data (3842)
Decentralized trials (1)
Denatured (20)
Depression (107)
Dermatology (41)
Diabetes (252)
Diagnostics (1895)
Digital health (20)
Diversity (3)
Diversity, equity & inclusion (19)
Drug discovery (181)
Drug pricing (128)
Drug shortages (16)
Duchenne muscular dystrophy (150)
Earnings (38787)
Editorial (29)
Employer branding (5)
Employer resources (56)
Events (44726)
Executive appointments (826)
FDA (9619)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (813)
Gene editing (114)
Generative AI (33)
Gene therapy (311)
GLP-1 (557)
Government (1608)
Grass and pollen (4)
Guidances (214)
Healthcare (4462)
Hematology (95)
HIV (24)
Huntington's disease (30)
IgA nephropathy (61)
Immunology and inflammation (115)
Immuno-oncology (44)
Indications (131)
Infectious disease (1086)
Inflammatory bowel disease (102)
Inflation Reduction Act (9)
Influenza (42)
Intellectual property (167)
Interviews (64)
IPO (6612)
IRA (33)
Job creations (2103)
Job search strategy (395)
JPM (35)
Kidney cancer (16)
Labor market (42)
Layoffs (254)
Leadership (14)
Legal (3547)
Liver cancer (44)
Longevity (12)
Lung cancer (362)
Lymphoma (255)
Machine learning (20)
Management (21)
Manufacturing (666)
Marketing (3)
MASH (126)
Medical affairs (1)
Medical device (2584)
Medtech (2634)
Mergers & acquisitions (10418)
Metabolic disorders (737)
mRNA (102)
Multiple sclerosis (87)
NASH (17)
Neurodegenerative disease (198)
Neuropsychiatric disorders (60)
Neuroscience (1537)
Neurotech (1)
NextGen: Class of 2026 (1723)
Non-profit (761)
Now hiring (25)
Obesity (344)
Opinion (182)
Ovarian cancer (114)
Pain (159)
Pancreatic cancer (141)
Parkinson's disease (157)
Partnered (13)
Patents (334)
Patient recruitment (360)
Peanut (23)
People (33053)
Pharmaceutical (34)
Pharmacy benefit managers (20)
Phase 1 (9743)
Phase 2 (16540)
Phase 3 (16641)
Pipeline (5115)
Policy (166)
Postmarket research (1507)
Preclinical (3720)
Press Release (28)
Prostate cancer (173)
Psychedelics (31)
Radiopharmaceuticals (185)
Rare diseases (676)
Real estate (2745)
Recruiting (22)
Regulatory (13503)
Reports (20)
Research institute (669)
Resumes & cover letters (62)
Rett syndrome (32)
RNA editing (9)
RSV (31)
Schizophrenia (112)
Series A (157)
Series B (108)
Service/supplier (1)
Sickle cell disease (66)
Special edition (11)
Spinal muscular atrophy (110)
Sponsored (12)
Startups (1729)
State (2)
Stomach cancer (7)
Supply chain (69)
Tariffs (71)
The Weekly (59)
Vaccines (407)
Venture capital (53)
Weight loss (201)
Women's health (65)
Worklife (4)
Date
Today (40)
Last 7 days (199)
Last 30 days (1024)
Last 365 days (13948)
2026 (7605)
2025 (13981)
2024 (15452)
2023 (17149)
2022 (22367)
2021 (23154)
2020 (21525)
2019 (16579)
2018 (13010)
2017 (15296)
2016 (14281)
2015 (16845)
2014 (13267)
2013 (11189)
2012 (11989)
2011 (12492)
2010 (11404)
Location
Africa (336)
Alabama (29)
Alaska (2)
Arizona (99)
Arkansas (4)
Asia (23509)
Australia (3213)
California (5563)
Canada (2136)
China (894)
Colorado (267)
Connecticut (227)
Delaware (206)
Europe (46748)
Florida (933)
Georgia (142)
Hawaii (1)
Idaho (11)
Illinois (561)
India (77)
Indiana (327)
Iowa (6)
Japan (390)
Kansas (90)
Kentucky (25)
Louisiana (11)
Maine (10)
Maryland (619)
Massachusetts (4214)
Michigan (76)
Minnesota (323)
Mississippi (1)
Missouri (63)
Montana (12)
Nebraska (10)
Nevada (28)
New Hampshire (25)
New Jersey (2113)
New Mexico (7)
New York (1631)
North Carolina (927)
North Dakota (3)
Northern California (2859)
Ohio (126)
Oklahoma (7)
Oregon (20)
Pennsylvania (1253)
Puerto Rico (18)
Rhode Island (22)
South America (519)
South Carolina (18)
South Dakota (1)
Southern California (2219)
Tennessee (101)
Texas (743)
United States (20949)
Utah (126)
Vermont (1)
Virginia (224)
Washington D.C. (43)
Washington State (376)
West Virginia (3)
Wisconsin (72)
Wyoming (2)
310,751 Results for "pivot pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout
After delaying a late-stage readout last year due to “irregularities” at certain study sites, pivotal data for Bristol Myers Squibb’s Cobenfy appear set to arrive later this year.
April 30, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera
June 17, 2026
·
6 min read
Press Releases
Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva
June 15, 2026
·
11 min read
Press Releases
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
June 8, 2026
·
6 min read
Manufacturing
Tanabe pens deal to sell plants to Towa in post-buyout pivot
After being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products.
July 8, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
June 4, 2026
·
8 min read
Press Releases
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for a Fully Implanted Cochlear Implant seeking FDA Approval
March 11, 2026
·
9 min read
Press Releases
VisCardia Implants First U.S. Patient in RECOVER-HF Pivotal Trial
July 9, 2026
·
3 min read
Regulatory
Amgen’s Tavneos troubles continue as
NEJM
retracts pivotal publication
Earlier this year, Amgen refused the FDA’s request to withdraw Tavneos from the market. Now, two researchers who participated in the original study to support the drug’s approval claim they did not know the primary endpoint was readjudicated after the study was unblinded.
June 30, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept)
July 9, 2026
·
9 min read
1 of 31,076
Next
